Sonovum
Sonovum GmbH is a medical technology company focused on transforming brain monitoring through non-invasive technologies. Their core product, UltraEASY 3L, utilizes Transcranial Transmission Ultrasound (TTUS®) to capture the 'Hirnpulskurve' (brain pulse curve), a biosignal used for classifying and monitoring neurological conditions. The company is developing AI-based classifiers for acute diagnostics and patient monitoring, specifically for assessing intracranial pressure (ICP) in severe traumatic brain injuries (TBI). A clinical trial, TTUS in TBI®, is ongoing in 13 hospitals across Germany. Sonovum's vision is to provide personalized therapy recommendations, enabled by AI-powered cohort analysis. They are certified under ISO 13485 for quality management and their products carry the CE marking.
Sonovum
Sonovum GmbH is a medical technology company focused on transforming brain monitoring through non-invasive technologies. Their core product, UltraEASY 3L, utilizes Transcranial Transmission Ultrasound (TTUS®) to capture the 'Hirnpulskurve' (brain pulse curve), a biosignal used for classifying and monitoring neurological conditions. The company is developing AI-based classifiers for acute diagnostics and patient monitoring, specifically for assessing intracranial pressure (ICP) in severe traumatic brain injuries (TBI). A clinical trial, TTUS in TBI®, is ongoing in 13 hospitals across Germany. Sonovum's vision is to provide personalized therapy recommendations, enabled by AI-powered cohort analysis. They are certified under ISO 13485 for quality management and their products carry the CE marking.